American Diabetes Association Introduces New Tool Kit To Help Providers Talk To Their Patients About Estimated Average Glucose

August 3, 2009

For years, the A1C blood test has given diabetes patients and health care providers an invaluable tool for measuring diabetes control and guiding treatment decisions. However, another value, called estimated Average Glucose (eAG), may start to show up on lab reports and provide health care providers with an easier way to talk with their patients about blood glucose control.

"Estimated average glucose is a new way to report glucose control based on the A1C test," said Sue McLaughlin, BS, RD, CDE, CPT, President, Health Care & Education, American Diabetes Association. "eAG will help patients better understand what their daily glucose testing means and if they are moving in the right direction when it comes to diabetes control."

To support health care providers, the American Diabetes Association is making available a new eAG Tool Kit to help patients better understand how their A1C relates to their daily diabetes management. The eAG Tool Kit offers easy-to-use health care provider and patient resources and supplies the necessary tools and materials to understand eAG. The kit contains a patient tear pad with information explaining the importance of eAG, an A1C to eAG conversion wheel, two 11" x 17" posters to hang up in patient exam rooms and an eAG to A1C calculator.

Health care professionals can request a free copy of the eAG toolkit by going to

eAG comes from a large international study called the A1C-Derived Average Glucose (ADAG) study. This study, which was published in Diabetes Care in August 2008, established that the A1C does, in fact, do what scientists have long believed it does: provide an accurate test of average blood glucose.

"The results of the ADAG study should give people with diabetes increased confidence that the A1C is, indeed, a valuable measurement of their average blood glucose," added McLaughlin.

The eAG Tool Kit is sponsored through a charitable contribution from Bristol-Myers Squibb and AstraZeneca.

About the American Diabetes Association

Nearly half of American adults have diabetes or prediabetes; more than 30 million adults and children have diabetes; and every 21 seconds, another individual is diagnosed with diabetes in the U.S. Founded in 1940, the American Diabetes Association (ADA) is the nation’s leading voluntary health organization whose mission is to prevent and cure diabetes, and to improve the lives of all people affected by diabetes. The ADA drives discovery by funding research to treat, manage and prevent all types of diabetes, as well as to search for cures; raises voice to the urgency of the diabetes epidemic; and works to safeguard policies and programs that protect people with diabetes. In addition, the ADA supports people living with diabetes, those at risk of developing diabetes, and the health care professionals who serve them through information and programs that can improve health outcomes and quality of life. For more information, please call the ADA at 1-800-DIABETES (1-800-342-2383) or visit Information from both of these sources is available in English and Spanish. Find us on Facebook (American Diabetes Association), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn)